[Federal Register Volume 88, Number 149 (Friday, August 4, 2023)]
[Notices]
[Page 51844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16685]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: August 29, 2023.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee meeting will include presentation, discussion,
and possible finalization of the Draft Report of the Working Group
on Data Science and Emerging Technology and will include discussion
of next steps for the Committee.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be
available at https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4/).
Contact Person: Jessica Tucker, Ph.D., Office of Science Policy,
National Institutes of Health, 6705 Rockledge Drive, Suite 630,
Bethesda, MD 20892, 301-496-9838, [email protected].
Members of the public may request to make an oral public comment
or may submit written public comments. To sign up to make an oral
public comment, please submit your name, affiliation, and short
description of the oral comment to the Contact Person listed on this
notice at least two business days prior to the meeting date. Once
all time slots are filled, only written comments will be accepted.
Any interested person may file written comments by forwarding the
statement to the Contact Person listed on this notice at least two
business days prior to the meeting date. The statement should
include the name, address, telephone number and, when applicable,
the business or professional affiliation of the interested person.
Other than name and contact information, please do not include any
personally identifiable information or any information that you do
not wish to make public. Proprietary, classified, confidential, or
sensitive information should not be included in your comments.
Please note that any comments NIH receives may be posted unredacted
to the Office of Science Policy website.
Information is also available on the NIH Office of Science
Policy website: https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4,
where an agenda, link to the webcast meeting, and any additional
information for the meeting will be posted when available. Materials
for this meeting will be posted prior to the meeting. Please check
this website for updates.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 1, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-16685 Filed 8-3-23; 8:45 am]
BILLING CODE 4140-01-P